Venkata Yellapantula
Venkata Yellapantula
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,#,
Malin Hultcrantz
Malin Hultcrantz
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
2Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
1,2,✉,#,
Even H Rustad
Even H Rustad
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,
Ester Wasserman
Ester Wasserman
3Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
3,
Dory Londono
Dory Londono
3Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
3,
Robert Cimera
Robert Cimera
3Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
3,
Amanda Ciardiello
Amanda Ciardiello
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,
Heather Landau
Heather Landau
4Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
4,
Theresia Akhlaghi
Theresia Akhlaghi
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,
Sham Mailankody
Sham Mailankody
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,
Minal Patel
Minal Patel
5Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
5,
Juan Santiago Medina-Martinez
Juan Santiago Medina-Martinez
5Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
5,
Juan Esteban Arango Ossa
Juan Esteban Arango Ossa
5Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
5,
Max Fine Levine
Max Fine Levine
5Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
5,
Niccolo Bolli
Niccolo Bolli
6University of Milan, Department of Oncology and Onco-Hematology, Milan, Italy
7Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Medical Oncology and Hematology, Milan, Italy
6,7,
Francesco Maura
Francesco Maura
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,
Ahmet Dogan
Ahmet Dogan
8Hematopathology Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
8,
Elli Papaemmanuil
Elli Papaemmanuil
5Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
9Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
5,9,#,
Yanming Zhang
Yanming Zhang
3Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
3,✉,#,
Ola Landgren
Ola Landgren
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
1,✉,#
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
2Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden
3Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
4Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
5Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
6University of Milan, Department of Oncology and Onco-Hematology, Milan, Italy
7Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Medical Oncology and Hematology, Milan, Italy
8Hematopathology Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA
9Epidemiology & Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA
Collection date 2020 Jan.
Subject terms: Genetics research, Cancer genomics
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
